Diabetes Digital Health, Telehealth, and Artificial Intelligence explains how to develop and use the emerging technologies of digital health, telehealth, and artificial intelligence to address this important public health problem to deliver new hardware, software, and processes. According to CDC, in the US there are 37 million people with diabetes and 96 million people with prediabetes. Diabetes triples the risk of myocardial infarction and stroke and is the leading cause of blindness, end stage renal failure, and amputations. The management of diabetes is becoming increasingly dominated by digital health tools consisting of wearable sensors, mobile applications providing decision support software, and wireless communication tools. Digital health provides new data streams that can be combined to create unique approaches for diabetes, based on a precision medicine paradigm. Diabetes Digital Health, Telehealth, and Artificial Intelligence explore trends in developing and deploying the three most important emerging technologies for diabetes: digital health, telehealth, and artificial intelligence. This book is essential to clinicians, scientists, engineers, industry professionals, regulators, and investors offering the tools that will be used to create the next generation products to support a precision medicine approach to manage diabetes.
Recenzijas
"...addresses the technological advances in the field of diabetes care that the healthcare field has used more frequently since the COVID-19 pandemic. [ It] shed light on the options, convenience, and efficiency of some current forms of diabetes care including office visits from home and messaging a care team through text messaging.... This book will be of interest to those who care for patients with diabetes and perhaps for patients with diabetes themselves since many have adapted well to the use of an insulin pump, one of the new forms of technology the book discusses. [ D]iscusses various topics such as virtual health visits, remote monitoring of diabetic complications, employing artificial intelligence in medication dosing, and much more. Each chapter includes a barriers section and a subsequent solution section.... Anyone interested in diabetes technology whether from a research or pharmaceutical standpoint will find this book useful." --©Doodys Review Service, 2024, Jessica Hwang, MD (Edward Hines, Jr. VA Hospital)
1. Diabetes and the Digital Divide
2. Digital Health and Pharmacoadherence
3. Using Digital Health Tools in Medical Practice
4. Electronic Health Record and Digital Health
5. Cybersecurity of Digital Health Tools
6. Economics of Digital Health?
7. Current state of Digital Health Regulation - FDA Perspective
8. Digital Health in Low and Middle Income Countries
9. Food Recognition and Nutritional Apps
10. CGM and Digital Health Tools for Lifestyle Modification
11. Virtual Reality for Diabetes Telehealth
12. Virtual Care: synchronous and asynchronous modalities in diabetes care
13. The Integration of Continuous Glucose Monitor Data into the EHR Project
14. Text Messaging for Diabetes
15. Outcomes of Telehealth Care
16. Economic Analysis of Diabetes Telehealth
17. Diabetes Education via Telehealth
18. Pediatric Telehealth for Diabetes
19. Trends in Digital Connectivity
20. Telehealth in Pregnancy
21. Ethics and Fairness for Diabetes Artificial Intelligence
22. AI for Diabetic Foot Ulcers
23. AI-Powered Tele-ophthalmology for Diabetic Retinopathy
24. Precision Monitoring for Diabetes
25. AI to Diagnose Diabetes
26. AI for Insulin Dosing in an Automated Insulin Delivery System
27. An Introduction to AI for Diabetes
28. AI to Support Self-management and Coaching
29. AI to Diagnose Glucotypes in Pre-diabetes
30. Machine Learning to Improve Inpatient Management of Diabetes
31. Natural Language Processing for Diabetes Digital Health
Dr. David C. Klonoff, MD, FACP, FRCP (Edin), is an endocrinologist specializing in the development of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF, USA. Dr. Klonoff received the American Diabetes Associations 2019 Outstanding Physician Clinician Award. He has received an FDA Directors Special Citation Award for outstanding contributions related to diabetes technology. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and co-founded the Digital Diabetes Congress. He chairs the Scientific Advisory Board for the Texas A&M University Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) Engineering Research Center. He is currently researching new devices and drugs for diabetes. Dr. Klonoff graduated from UC Berkeley and UCSF Medical School and did five years of internal medicine and endocrinology training at UCLA and UCSF. David Kerr MBChB, DM, FRCP, FRCPE, is a UK trained endocrinologist and has recently joined Sutter Health after spending almost a decade as a researcher/innovator in Santa Barbara, CA (https://www.davidkerrmd.com/). This began in 2014, with Davids appointment as Director of Research and Innovation at Sansum Diabetes Research Institute before moving to the Diabetes Technology Society as their lead for Digital Health last year. David has now joined Sutter Health as Senior Investigator, Diabetes Research and Digital Health Equity.
Davids recent research has focused on offering wearable digital health technologies such as continuous glucose monitors to marginalized and historically excluded communities to help understand the potential value of real time physiological data. He has published more than 400 articles, commentaries and opinion pieces as well as co-authoring the first two books focusing on diabetes and digital health.
Davids research has also included the use of food-as-medicine for adults with or at-risk of diabetes. As part of this research, increasing participation in clinical research by traditionally hard to reach communities has been achieved through the creation of specially trained Community Scientists from the same communities. David also has an adjunct position in the Dept of Computer Science and Electrical Engineering at Rice University in Houston Texas, and recently co-Chair of an NIDDK working group looking at the impact of innovation on furthering research into the heterogeneity of diabetes.
You can follow David on X at @godiabetesmd.
Dr. Juan Espinoza is Director of the West Coast Consortium for Technology & Innovation Paediatrics) which is working with a $6.6 million FDA grant. Dr. Espinoza and Klonoff are co-Chairs of iCoDE, the multistakeholder project to create a standard for automatic integration of continuous glucose monitor data into the election health record.
Biežāk uzdotie jautājumi par e-grāmatām